Categories: DiagnosticsResearchUniversity
Detect oral cancer early with Oro Lesion, a non-invasive salivary DNA test that guides timely interventions and improves patient outcomes.
Investors 1
Mentions in press and media 4
| Date | Title | Description |
| 27.04.2026 | OrisDX and HPV Cancers Alliance Partner to Break the Silence on Oral Cancer During National Awareness Month | Bridging clinical innovation and patient advocacy to drive early detection and humanize the fight against HPV-Related oral cancers. CHICAGO, IL, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- In observance of Oral Cancer Awareness Mont... |
| 07.01.2026 | OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection | OrisDX and Teledentistry.com Partnership
Combining virtual dental care with licensed dentists and an innovative oral cancer diagnostics solution ensures all patients will receive the care they deserve. CHICAGO, IL, UNITED STATES, January 7,... |
| 16.10.2025 | OrisDX Founder Lab at University of Chicago Awarded $250,000 to Enhance Oral Cancer Detection Technology | OrisDX receives $250K CBC award to boost HPV oral cancer test, launches new site, and heads to HLTH 2025. CHICAGO, IL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- OrisDX is proud to announce that the Founders of OrisDX Lab at the ... |
| - | OrisDX | “OrisDX” |
Reviews 0
